CND Life Sciences
PrivateLast Round
Seed Round
Jun 9, 2026
Total Funding Raised
$34.72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CND Life Sciences operates in Healthcare & Life Sciences and is based in Scottsdale, Arizona. Its latest recorded funding round was a Grant round in October 2025.
CND Life Sciences is a biotechnology company that provides a diagnostic test to aid in the confirmation of synucleinopathies like Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CND Life Sciences Comparables
Compare CND Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SYNAPS Dx | 85% | |
| Amprion | 84% | |
| Neurocode USA, Inc. | 79% |
For institutional investors. Book with your work email.
CND Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 9, 2026 | ||||
| Grant | Oct 22, 2025 | ||||
| Series A | May 1, 2025 | ||||
| Grant | Nov 20, 2024 | ||||
| Early Funding | Mar 20, 2024 | ||||
Grant | May 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CND Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VILAS Ventures | Series A |
| Top Corner Capital | Series A, Grant |
| Lupo Labs | Series A |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cambrian Growth Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Raised $4.3M in Seed funding.
- Oct 22, 2025
Secured $3M in grant funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesSep 19, 2026
CND Life Sciences, Inc. opens a dedicated Innovation Laboratory in Arizona, adding research and product-development capacity separate from its regulated clinical laboratory operations.
- expands_facilitiesSep 18, 2026
CND Life Sciences, Inc. opens a dedicated Innovation Laboratory in Scottsdale on Sep 17th '26, adding space for assay development, biomarker research, technology evaluation, and translational research.
For institutional investors. Book with your work email.
CND Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CND Life Sciences's valuation, stock price, and market status.
Is CND Life Sciences a public or private company?
CND Life Sciences is a private company.
What is the current stock price of CND Life Sciences?
CND Life Sciences is a private company, so its shares have no public market price. Caplight tracks CND Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CND Life Sciences worth (valuation)?
Valuation information for CND Life Sciences is not publicly available.
Can I buy CND Life Sciences stock?
CND Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CND Life Sciences's last funding round?
CND Life Sciences's most recent funding round was Seed Round on June 9, 2026.
Who are the main investors in CND Life Sciences?
Key investors in CND Life Sciences include VILAS Ventures, Top Corner Capital, Lupo Labs, NIH RADx, National Institute on Aging.
Will CND Life Sciences IPO soon?
No public IPO plans have been announced for CND Life Sciences.
How can I track CND Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in CND Life Sciences's shares on secondary markets.